Viral Assay, ToxGlo™, Promega
Supplier: Promega Corporation
The Viral ToxGlo Assay is a simple, quantifiable method of determining viral-induced cytopathic effects (CPE) in host cells caused by lytic virions. The assay measures cellular ATP as a surrogate measure of host cell viability.
- Determine Viral CPE or Monitor Compounds for Antiviral Activity
- Easy, simple protocol measures ATP
- Quantifiable assay for measuring viral-induced cytopathic effect (CPE)
- Compatible with high-throughput screening
The Viral ToxGlo Assay is a simple, quantifiable method of determining viral-induced cytopathic effects (CPE) in host cells caused by lytic virions. The assay measures cellular ATP as a surrogate measure of host cell viability. When CPE occurs due to viral infection, ATP depletion can be measured and correlated with viral burden. The amount of ATP detected is directly proportional to the number of viable host cells in culture and can be used as a simple method to quantify viral-induced CPE. The homogeneous "add-mix-measure" assay procedure involves adding the single reagent (ATP Detection Reagent) directly to host cells following viral treatment. A “glow-type” luminescent signal is generated that is proportional to the amount of ATP present. Cell washing, multiple pipetting steps and visual assessment are not required to assess CPE. The system detects as few as 15 cells/well in a 384-well format in 10 minutes after reagent addition and mixing and is designed for use in multiwell formats, making it ideal for automated high-throughput screening (HTS).
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...